Short Title:
OD Treatment Access
Initial Announcement
Back to the Grants Dashboard
Notice of Funding Opportunity (NOFO)
NOFO Number: TI-23-004
Posted on Grants.gov: Monday, January 23, 2023
Application Due Date: Friday, March 24, 2023
Catalog of Federal Domestic Assistance (CFDA) Number: 93.243
Intergovernmental Review (E.O. 12372): Applicants must comply with E.O. 12372 if their state(s) participates. Review process recommendations from the State Single Point of Contact (SPOC) are due no later than 60 days after application deadline.
Public Health System Impact Statement (PHSIS) / Single State Agency Coordination: Applicants must send the PHSIS to appropriate State and local health agencies by application deadline. Comments from Single State Agency are due no later than 60 days after application deadline.
Description
The purpose of this program is to expand access to naloxone and other Food and Drug Administration (FDA) approved overdose reversal medications for emergency treatment of known or suspected opioid overdose. The recipients will collaborate with other prescribers at the community level to implement trainings on policies, procedures, and models of care for prescribing, co-prescribing, and expanding access to naloxone and other FDA-approved overdose reversal medications to the specified population of focus (i.e., rural or urban).
Eligibility
Eligibility is limited to FQHCs (as defined in section 1861(aa) of the Social Security Act), opioid treatment programs as defined under part 8 of title 42, Code of Federal Regulations, and practitioners dispensing narcotic drugs pursuant to section 303(g) of the Controlled Substances Act (including secondary and higher education settings).
Award Information
Funding Mechanism: Cooperative Agreement
Anticipated Total Available Funding: Up to $1,400,000
Anticipated Number of Awards: 7
Anticipated Award Amount: Up to $200,000 per year per award
Length of Project: Up to 5 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $200,000 in total costs (direct and indirect) in any year of the proposed project. Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information
Program and Eligibility Questions
Kristen K. Harper
Center for Substance Abuse Prevention
Division of Targeted Prevention
Substance Abuse and Mental Health Services Administration
(240) 276-2420
kristen.harper@samhsa.hhs.gov
Financial and Budget Questions
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
(240) 276-1400
FOACSAT@samhsa.hhs.gov